10X Genomics Inc (TXG) Stock Price, Quote & News

Company Profile

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and singl...

Industry: Health Information Services

Sector: Healthcare

Phone: 925 401 7300

Website: www.10xgenomics.com

Address:

6230 Stoneridge Mall Road, Pleasanton, United States

WAJeff Jul. 23 at 3:19 PM

Some $TXG sold at $49, $49.50 52 week high

0 · Reply

longshortequities Jul. 22 at 4:58 PM

$TXG my heavens. Does this stock ever have a proper pullback? Target buy @ $35

0 · Reply

WAJeff Jul. 22 at 4:09 PM

$TXG $47.80 52 week high

0 · Reply

Avocado_smash Jul. 22 at 4:17 AM

$TXG PT 54++ 🚀🚀

0 · Reply

Nick_Drendel Jul. 22 at 1:25 AM

Leader $TXG vs Laggard $TEM The difference stock selection makes in a hot group.

0 · Reply

WOLFSTREET Jul. 21 at 9:07 PM

$TXG Haters Gonna Hate

0 · Reply

WOLFSTREET Jul. 21 at 9:06 PM

$TXG When stocks run 300% from my CC post, of course, consensus is going to be to "SHORT", totally understandable, but not my strategy. Fully loaded at $13 as posted and will follow the CC guidance to the finish-line. Absolutely expects stocks to go up and down, its a process we all know and adore.

0 · Reply

WOLFSTREET Jul. 21 at 9:03 PM

$TXG Yet stock is up 70%, that is 70! A "7" and a "0" I use CC and read absolutely nothing, reading is the enemy.

0 · Reply

WOLFSTREET Jul. 21 at 9:01 PM

$TXG

0 · Reply

WOLFSTREET Jul. 21 at 8:58 PM

$TXG What a BULL!

0 · Reply

10x Genomics announces research collaboration with Lausanne University Hospital

Jul 29, 2026, 9:00 AM EDT - 20 hours ago

10x Genomics and Lausanne University Hospital Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies for Cancer Care

2026-07-17T12:45:11.000Z - 12 days ago

10x Genomics price target raised to $40 from $23 at Leerink

Jul 15, 2026, 4:05 PM EDT - 14 days ago

10x Genomics to Report Second Quarter 2026 Financial Results on August 6, 2026

2026-07-15T12:46:15.000Z - 14 days ago

10x Genomics price target raised to $47 from $25 at TD Cowen

2026-07-14T11:00:55.000Z - 15 days ago

10x Genomics price target raised to $50 from $32 at Canaccord

2026-07-09T11:00:55.000Z - 20 days ago

10x Genomics price target raised to $37 from $22 at Morgan Stanley

Jul 8, 2026, 3:07 PM EDT - 21 days ago

10x Genomics Transcript: Transcript

2026-07-08T10:45:32.000Z - 21 days ago

10x Genomics price target raised to $45 from $24 at Citi

2026-06-24T08:50:19.000Z - 5 weeks ago

10x Genomics price target raised to $40 from $30 at Barclays

Jun 17, 2026, 5:00 PM EDT - 6 weeks ago

Torex Gold Announces Results of Its 2026 Meeting of Shareholders

2026-06-17T13:07:30.000Z - 6 weeks ago

10x Genomics announces research collaboration with Cleveland Clinic

Jun 17, 2026, 9:00 AM EDT - 6 weeks ago

10x Genomics and Cleveland Clinic Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies in Patients with Bladder Cancer

ADC

2026-06-09T13:11:53.000Z - 7 weeks ago

10x Genomics acquires Proteintech Genomics

Jun 9, 2026, 9:00 AM EDT - 7 weeks ago

10x Genomics Acquires Proteintech Genomics, a Division Within Proteintech Group

May 13, 2026, 8:00 PM EDT - 2 months ago

10x Genomics Transcript: Bank of America Global Healthcare Conference 2026

2026-05-12T15:27:11.000Z - 2 months ago

10x Genomics price target raised to $22 from $20 at Morgan Stanley

2026-05-12T12:26:29.000Z - 2 months ago

10x Genomics price target raised to $20 from $17 at JPMorgan

2026-05-08T16:10:27.000Z - 2 months ago

10x Genomics price target raised to $23 from $17 at Deutsche Bank

2026-05-07T21:30:11.000Z - 2 months ago

10x Genomics reports Q1 EPS (10c), consensus (6c)

2026-05-07T21:28:54.000Z - 2 months ago

10x Genomics backs FY26 revenue view $600M-$625M, consensus $612.74M

May 7, 2026, 4:30 PM EDT - 2 months ago

10x Genomics Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 2 months ago

10x Genomics Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 2 months ago

10x Genomics Quarterly report: Q1 2026

May 7, 2026, 4:05 PM EDT - 2 months ago

10x Genomics Reports First Quarter 2026 Financial Results

Apr 29, 2026, 4:05 PM EDT - 3 months ago

10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference

Apr 24, 2026, 8:00 AM EDT - 3 months ago

10x Genomics Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 3 months ago

10x Genomics Proxy statement: Proxy filing

Apr 23, 2026, 7:00 AM EDT - 3 months ago

LiquidCell Dx Appoints Former Foundation Medicine, 10x Genomics and IDT Leader Mirna Jarosz as Chief Executive Officer; Names Former Foundation Medicine Chief Medical Officer Vincent A. Miller, MD, Senior Strategic Advisor

2026-04-20T14:03:59.000Z - 3 months ago

10x Genomics price target raised to $32 from $22 at Canaccord

2026-04-20T13:43:54.000Z - 3 months ago

10x Genomics price target raised to $30 from $21 at BofA

2026-04-19T17:10:44.000Z - 3 months ago

10x Genomics announces Atera, a new in situ spatial biology platform

Apr 18, 2026, 10:00 PM EDT - 3 months ago

10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood

Apr 17, 2026, 7:00 AM EDT - 3 months ago

10x Genomics Slides: Corporate presentation

Apr 15, 2026, 4:05 PM EDT - 3 months ago

10x Genomics to Report First Quarter 2026 Financial Results on May 7, 2026

2026-04-14T10:50:31.000Z - 3 months ago

10x Genomics price target raised to $30 from $22 at Barclays

Mar 25, 2026, 7:00 AM EDT - 4 months ago

Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs

Mar 17, 2026, 8:00 AM EDT - 4 months ago

PerturbAI Launches from Stealth, Unveils the World's Largest In Vivo CRISPR Atlas

Mar 3, 2026, 11:50 AM EST - 5 months ago

10x Genomics Transcript: TD Cowen 46th Annual Health Care Conference

Feb 19, 2026, 4:05 PM EST - 5 months ago

10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference

Feb 12, 2026, 4:30 PM EST - 5 months ago

10x Genomics Earnings Call Transcript: Q4 2025

Feb 12, 2026, 4:30 PM EST - 5 months ago

10x Genomics Annual report: Q4 2025

Feb 12, 2026, 4:30 PM EST - 5 months ago

10x Genomics Earnings release: Q4 2025

Feb 12, 2026, 4:05 PM EST - 5 months ago

10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026

Feb 4, 2026, 9:00 AM EST - 6 months ago

PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology

Jan 22, 2026, 4:05 PM EST - 6 months ago

10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026

Jan 12, 2026, 11:15 AM EST - 7 months ago

10x Genomics Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 11:15 AM EST - 7 months ago

10x Genomics Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 9:11 AM EST - 7 months ago

10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease

Jan 12, 2026, 9:10 AM EST - 7 months ago

10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling

Jan 12, 2026, 9:00 AM EST - 7 months ago

Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology

Jan 11, 2026, 12:00 PM EST - 7 months ago

10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results

Jan 7, 2026, 7:05 AM EST - 7 months ago

CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response

CDNA

Dec 29, 2025, 4:05 PM EST - 7 months ago

10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Nov 18, 2025, 11:20 AM EST - 9 months ago

10x Genomics Transcript: Wolfe Research Healthcare Conference 2025

Nov 18, 2025, 9:00 AM EST - 9 months ago

New ASTRA Consortium Unites Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas Powered by 10x Genomics' Xenium

Nov 11, 2025, 4:05 PM EST - 9 months ago

10x Genomics to Participate in the Wolfe Research Healthcare Conference 2025

Nov 6, 2025, 4:30 PM EST - 9 months ago

10x Genomics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 9 months ago

10x Genomics Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 9 months ago

10x Genomics Earnings release: Q3 2025

Nov 6, 2025, 4:05 PM EST - 9 months ago

10x Genomics Reports Third Quarter 2025 Financial Results

Oct 29, 2025, 9:00 AM EDT - 9 months ago

10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research

Oct 20, 2025, 12:30 PM EDT - 10 months ago

10x Genomics and Anthropic Partner to Make Single Cell and Spatial Analysis More Accessible Through Claude for Life Sciences

Oct 9, 2025, 4:05 PM EDT - 10 months ago

10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025

Oct 9, 2025, 8:00 AM EDT - 10 months ago

Parse Biosciences Invalidates Scale Biosciences (now 10x Genomics) Patent

Sep 10, 2025, 11:30 AM EDT - 11 months ago

10x Genomics Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 9, 2025, 9:00 AM EDT - 11 months ago

CLISEQ, 10X Genomics and Weizmann Institute to Investigate Single Cell Applications in Hematology Clinical Diagnostics

Aug 27, 2025, 4:05 PM EDT - 1 year ago

10x Genomics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 19, 2025, 9:00 AM EDT - 1 year ago

10x Genomics Launches Xenium Protein, Advancing Spatial Biology by Enabling Same-Cell RNA and Protein Analysis

Aug 7, 2025, 4:30 PM EDT - 1 year ago

10x Genomics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

10x Genomics Quarterly report: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

10x Genomics Earnings release: Q2 2025

Aug 7, 2025, 4:05 PM EDT - 1 year ago

10x Genomics Reports Second Quarter 2025 Financial Results

Aug 7, 2025, 4:04 PM EDT - 1 year ago

10x Genomics to Acquire Scale Biosciences

Jul 17, 2025, 9:00 AM EDT - 1 year ago

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

Jul 10, 2025, 4:05 PM EDT - 1 year ago

10x Genomics to Report Second Quarter 2025 Financial Results on August 7, 2025

May 14, 2025, 4:05 PM EDT - 1 year ago

10x Genomics Announces Patent Litigation Settlement Agreement with Bruker

May 13, 2025, 2:20 PM EDT - 1 year ago

10x Genomics Transcript: Bank of America 2025 Healthcare Conference

May 8, 2025, 4:30 PM EDT - 1 year ago

10x Genomics Earnings Call Transcript: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

10x Genomics Quarterly report: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

10x Genomics Earnings release: Q1 2025

May 8, 2025, 4:05 PM EDT - 1 year ago

10x Genomics Reports First Quarter 2025 Financial Results

Apr 30, 2025, 4:05 PM EDT - 1 year ago

10x Genomics to Participate in the BofA Securities 2025 Healthcare Conference

Apr 15, 2025, 8:00 AM EDT - 1 year ago

10x Genomics Proxy statement: Proxy Filing

Apr 14, 2025, 8:00 AM EDT - 1 year ago

10x Genomics Proxy statement: Proxy Filing

Apr 3, 2025, 8:00 AM EDT - 1 year ago

Vizgen Announces End of Litigation with 10x Genomics and Harvard University

Mar 4, 2025, 11:10 AM EST - 1 year ago

10x Genomics Transcript: TD Cowen 45th Annual Healthcare Conference

Mar 3, 2025, 4:05 PM EST - 1 year ago

10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products

Feb 23, 2025, 11:30 AM EST - 1 year ago

10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis

Feb 18, 2025, 4:05 PM EST - 1 year ago

10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference

Feb 12, 2025, 7:19 PM EST - 1 year ago

Trump's Cuts to Medical Research Are Hurting These Stocks

ILMN PACB

Feb 12, 2025, 4:30 PM EST - 1 year ago

10x Genomics Earnings Call Transcript: Q4 2024

Feb 12, 2025, 4:30 PM EST - 1 year ago

10x Genomics Annual report: Q4 2024

Feb 12, 2025, 4:30 PM EST - 1 year ago

10x Genomics Earnings release: Q4 2024

Feb 12, 2025, 4:05 PM EST - 1 year ago

10x Genomics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Outlook for 2025

Feb 6, 2025, 8:30 AM EST - 1 year ago

Chan Zuckerberg Initiative Launches Billion Cells Project with 10x Genomics and Ultima Genomics to Advance AI in Biology

Feb 4, 2025, 8:59 AM EST - 1 year ago

Parse Biosciences Invalidates All 10x Genomics' Patent Claims Asserted Against Its Products

Jan 31, 2025, 6:34 AM EST - 1 year ago

Spatial Omics Research Report 2023-2034: Market to reach $1.09 Billion - 10x Genomics Enhances Spatial OMICS with New Visium Spatial Gene Expression for FFPE

Jan 28, 2025, 4:05 PM EST - 1 year ago

10x Genomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 12, 2025

Jan 13, 2025, 10:30 AM EST - 1 year ago

10x Genomics Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 13, 2025, 10:30 AM EST - 1 year ago

10x Genomics Slides: FY 2025

Jan 2, 2025, 4:05 PM EST - 1 year ago

10x Genomics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

WAJeff Jul. 23 at 3:19 PM

Some $TXG sold at $49, $49.50 52 week high

0 · Reply

longshortequities Jul. 22 at 4:58 PM

$TXG my heavens. Does this stock ever have a proper pullback? Target buy @ $35

0 · Reply

WAJeff Jul. 22 at 4:09 PM

$TXG $47.80 52 week high

0 · Reply

Avocado_smash Jul. 22 at 4:17 AM

$TXG PT 54++ 🚀🚀

0 · Reply

Nick_Drendel Jul. 22 at 1:25 AM

Leader $TXG vs Laggard $TEM The difference stock selection makes in a hot group.

0 · Reply

WOLFSTREET Jul. 21 at 9:07 PM

$TXG Haters Gonna Hate

0 · Reply

WOLFSTREET Jul. 21 at 9:06 PM

0 · Reply

WOLFSTREET Jul. 21 at 9:03 PM

$TXG Yet stock is up 70%, that is 70! A "7" and a "0" I use CC and read absolutely nothing, reading is the enemy.

0 · Reply

WOLFSTREET Jul. 21 at 9:01 PM

$TXG

0 · Reply

WOLFSTREET Jul. 21 at 8:58 PM

$TXG What a BULL!

0 · Reply

WOLFSTREET Jul. 21 at 8:58 PM

$TXG 300% What's not to LOVE about CC Is this not "CALM CONFIDENCE"? Who would question it? Someone who can't read I guess...

0 · Reply

RunnerSignals Jul. 21 at 8:08 PM

$VOR $HRMY $TROX $TXG $PLTK flipped red to green and finished strong. real accumulation or one-day squeeze? the closing tape leaves a clue

0 · Reply

BioGem Jul. 15 at 6:29 PM

$TXG Very shortable at this level. Extremely pumped by analysts with stratospheric valuation (5.7B$) no matter what dreams management is selling. Multiple negatives: -Continuous bottom lines losses with no end in sight. No profitability will be achieved in years. -Tepid revenue throughout 2026 per guidance. -Poor margins. -High dilution from stock awards non-stop. -Insiders, including CEO, sell every single month. -Many hiccups will happen with their new products launches and delays are the norm. Expenses will spike. -High short interest = consensus of poor performance.

5 · Reply

Avocado_smash Jul. 15 at 4:54 AM

$TXG Boom boom 🚀🚀🚀

0 · Reply

Spicy_Trade Jul. 14 at 11:45 PM

10x Genomics, Inc. ( $TXG ) SpicyTrade - Daily Stock Analysis https://youtu.be/c6Z2S6QGQK0?si=BC6JMfdNlmv-VFn0

0 · Reply

itrekntravel Jul. 14 at 6:05 PM

$TXG nice moves today

0 · Reply

WAJeff Jul. 14 at 5:31 PM

$TXG 45.52 52 week high

0 · Reply

WAJeff Jul. 14 at 1:45 PM

$TXG $44.12 52 week high

0 · Reply

CarterEllis Jul. 9 at 9:34 PM

Healthcare & Biotech are absolutely DOMINATING! Top 5 52-week high breakouts today! Smart money is heavily chasing beta across the tape, triggering massive momentum expansions: $FBRX (+78%) Total showstopper! Blew the doors off with spectacular Phase 1b vitiligo data (84% improved, 0% worsened), forcing a massive institutional short squeeze! $TRAX (+56%) $BBIO (+15%) $TXG (+15%) $MFP (+13%) The biotech sector rotation is officially in overdrive. Strong volume is locking the float on these high-conviction breakout setups! "The battle map has been shared in the community! Are you going to miss out again?"

0 · Reply

WalterWhite13 Jul. 9 at 8:34 PM

$TXG @BudskieMcgee

0 · Reply

WalterWhite13 Jul. 9 at 2:20 PM

$TXG how does this company only have 2800 followers? Meanwhile a microcap of $EDSA has 10,000 more followers.

2 · Reply

Wallstfan Jul. 8 at 2:50 PM

$TXG buying the dip!

0 · Reply

Market Cap	5.97B
Revenue (ttm)	642.82M
Net Income (ttm)	-43.54M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-6.77%
Debt to Equity Ratio	0.00

Volume	2,390,900
Avg Vol	3,240,000
Day's Range	N/A - N/A
Shares Out	126.96M
Stochastic %K	58%
Beta	2.05
Analysts	Sell
Price Target	$40.43